Marina Ol'khovich

Dr. Marina Ol'khovich


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
SBSvetlana Blokhina
Svetlana Blokhina
ASAngelica Sharapova
Angelica Sharapova
MOMarina Ol'khovich
Marina Ol'khovich
ТVТatyana V. Volkova
Тatyana V. Volkova
German PerlovichGerman Perlovich
German Perlovich

1 August 2019 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
LPLaura Perissinotti
Laura Perissinotti
JGJiqing Guo
Jiqing Guo
MKMeruyert Kudaibergenova
Meruyert Kudaibergenova
JLJames Lees-Miller
James Lees-Miller
MOMarina Ol'khovich
Marina Ol'khovich
HDHenry J. Duff
Henry J. Duff
Abnormal cardiac electrical activity is a common side effect caused by unintended block of the promiscuous drug target human ether-à-go-go-related gene (hERG1), the pore-forming domain of the delayed rectifier K+ channel in the heart. hERG1 block leads to a prolongation of the QT interval, a phase of the cardiac cycle that underlies myocyte repolarization detectable on the electrocardiogram. Even newly released drugs such as heart-rate lowering agent ivabradine block the rapid delayed rectifier current IKr, prolong action potential duration, and induce potentially lethal arrhythmia known as torsades de pointes. In this study, we describe a critical drug-binding pocket located at the lateral pore surface facing the cellular membrane. Mutations of the conserved M651 residue alter ivabradine-induced block but not by the common hERG1 blocker dofetilide. As revealed by molecular dynamics simulations, binding of ivabradine to a lipophilic pore access site is coupled to a state-dependent reorientation of aromatic residues F557 and F656 in the S5 and S6 helices. We show that the M651 mutation impedes state-dependent dynamics of F557 and F656 aromatic cassettes at the protein-lipid interface, which has a potential to disrupt drug-induced block of the channel. This fundamentally new mechanism coupling the channel dynamics and small-molecule access from the membrane into the hERG1 intracavitary site provides a simple rationale for the well established state-dependence of drug blockade. SIGNIFICANCE STATEMENT The drug interference with the function of the cardiac hERG channels represents one of the major sources of drug-induced heart disturbances. We found a novel and a critical drug-binding pocket adjacent to a lipid-facing surface of the hERG1 channel, which furthers our molecular understanding of drug-induced QT syndrome.

1 February 2017 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
SBSvetlana Blokhina
Svetlana Blokhina
ASAngelica Sharapova
Angelica Sharapova
MOMarina Ol'khovich
Marina Ol'khovich
German PerlovichGerman Perlovich
German Perlovich

1 July 2017 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
MOMarina Ol'khovich
Marina Ol'khovich
ASAngelica Sharapova
Angelica Sharapova
German PerlovichGerman Perlovich
German Perlovich
SSSofia Ya. Skachilova
Sofia Ya. Skachilova
NZNikolai K. Zheltukhin
Nikolai K. Zheltukhin

1 April 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SBSvetlana Blokhina
Svetlana Blokhina
TVTatyana V. Volkova
Tatyana V. Volkova
MOMarina Ol'khovich
Marina Ol'khovich
ASAngelica Sharapova
Angelica Sharapova
APAlexey N. Proshin
Alexey N. Proshin
German PerlovichGerman Perlovich
German Perlovich

1 May 2019 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
SBSvetlana Blokhina
Svetlana Blokhina
ASAngelica Sharapova
Angelica Sharapova
MOMarina Ol'khovich
Marina Ol'khovich
GPGerman Perlovich
German Perlovich